144 related articles for article (PubMed ID: 33660034)
21. Association of osteolytic lesions, bone mineral loss and trabecular sclerosis with prevalent vertebral fractures in patients with multiple myeloma.
Borggrefe J; Giravent S; Campbell G; Thomsen F; Chang D; Franke M; Günther A; Heller M; Wulff A
Eur J Radiol; 2015 Nov; 84(11):2269-74. PubMed ID: 26283192
[TBL] [Abstract][Full Text] [Related]
22. Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma.
Razek AA; Ezzat A; Azmy E; Tharwat N
Radiol Med; 2013 Aug; 118(5):799-805. PubMed ID: 22986700
[TBL] [Abstract][Full Text] [Related]
23. Vertebral lesion distribution in multiple myeloma--assessed by reduced-dose whole-body MDCT.
Bier G; Kloth C; Schabel C; Bongers M; Nikolaou K; Horger M
Skeletal Radiol; 2016 Jan; 45(1):127-33. PubMed ID: 26476728
[TBL] [Abstract][Full Text] [Related]
24. Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.
Simeone FJ; Harvey JP; Yee AJ; O'Donnell EK; Raje NS; Torriani M; Bredella MA
Skeletal Radiol; 2019 May; 48(5):773-779. PubMed ID: 30218303
[TBL] [Abstract][Full Text] [Related]
25. [Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].
Baur-Melnyk A; Reiser M
Radiologe; 2004 Sep; 44(9):874-81. PubMed ID: 15365631
[TBL] [Abstract][Full Text] [Related]
26. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
28. Differentiating diffuse from focal pattern on Computed Tomography in multiple myeloma: Added value of a Radiomics approach.
Tagliafico AS; Cea M; Rossi F; Valdora F; Bignotti B; Succio G; Gualco S; Conte A; Dominietto A
Eur J Radiol; 2019 Dec; 121():108739. PubMed ID: 31733431
[TBL] [Abstract][Full Text] [Related]
29. Subspecialty Second-Opinion in Multiple Myeloma CT: Emphasis on Clinically Significant Lytic Lesions.
Tagliafico AS; Belgioia L; Bonsignore A; Rossi F; Succio G; Bignotti B; Dominietto A
Medicina (Kaunas); 2020 Apr; 56(4):. PubMed ID: 32340143
[No Abstract] [Full Text] [Related]
30. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
[TBL] [Abstract][Full Text] [Related]
31. Automated "Bone Subtraction" Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma.
Horger M; Ditt H; Liao S; Weisel K; Fritz J; Thaiss WM; Kaufmann S; Nikolaou K; Kloth C
Acad Radiol; 2017 May; 24(5):623-632. PubMed ID: 28256439
[TBL] [Abstract][Full Text] [Related]
32. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study.
Schulze M; Weisel K; Grandjean C; Oehrlein K; Zago M; Spira D; Horger M
AJR Am J Roentgenol; 2014 Jan; 202(1):170-9. PubMed ID: 24370141
[TBL] [Abstract][Full Text] [Related]
33. Whole-Body Low-Dose Computed Tomography (WBLDCT) in Assessment of Patients with Multiple Myeloma - Pilot Study and Standard Imaging Protocol Suggestion.
Chrzan R; Jurczyszyn A; Urbanik A
Pol J Radiol; 2017; 82():356-363. PubMed ID: 28740565
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Whole-Body DWI and
Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
[No Abstract] [Full Text] [Related]
35. Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned.
Bier G; Mustafa DF; Kloth C; Weisel K; Ditt H; Nikolaou K; Horger M
AJR Am J Roentgenol; 2016 Jan; 206(1):57-63. PubMed ID: 26700335
[TBL] [Abstract][Full Text] [Related]
36. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J
Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378
[TBL] [Abstract][Full Text] [Related]
37. Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.
Horger M; Fritz J; Thaiss WM; Ditt H; Weisel K; Haap M; Kloth C
Skeletal Radiol; 2018 Mar; 47(3):351-361. PubMed ID: 29222688
[TBL] [Abstract][Full Text] [Related]
38. Role of imaging in multiple myeloma.
Baffour FI; Glazebrook KN; Kumar SK; Broski SM
Am J Hematol; 2020 Aug; 95(8):966-977. PubMed ID: 32350883
[TBL] [Abstract][Full Text] [Related]
39. Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma.
Breyer RJ; Mulligan ME; Smith SE; Line BR; Badros AZ
Skeletal Radiol; 2006 Sep; 35(9):632-40. PubMed ID: 16758246
[TBL] [Abstract][Full Text] [Related]
40. Improved MDCT monitoring of pelvic myeloma bone disease through the use of a novel longitudinal bone subtraction post-processing algorithm.
Horger M; Thaiss WM; Ditt H; Weisel K; Fritz J; Nikolaou K; Liao S; Kloth C
Eur Radiol; 2017 Jul; 27(7):2969-2977. PubMed ID: 27882427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
